Market Overview

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

115.63 -2.35 (-1.99%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/19/19Chardan CapitalMaintainsBuy190.0
12/18/19Cantor FitzgeraldReiteratesOverweight176.0
12/17/19Morgan StanleyMaintainsOverweight150.0
11/25/19BMO CapitalMaintainsOutperform143.0
11/21/19BMO CapitalMaintainsOutperform138.0
11/21/19Morgan StanleyMaintainsOverweight141.0
11/21/19Cantor FitzgeraldMaintainsOverweight159.0
11/21/19BarclaysMaintainsOverweight131.0
11/20/19OppenheimerInitiates Coverage OnOutperform128.0
11/13/19Bank of AmericaInitiates Coverage OnBuy110.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter